(Q60442187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

phase I clinical trial

1 reference

1 reference

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Fabio Parazzini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

G Bolis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Scarfone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Zanaboni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Villa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Presti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Melpignano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Tateo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Guarnerio

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Gentile

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

592-595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

Taxol: a new drug with significant activity as a salvage therapy in advanced epithelial ovarian carcinoma.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900495-9

7 January 2021

Taxol and taxotere--current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900495-9

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900495-9

7 January 2021

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900495-9

7 January 2021

Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900495-9

7 January 2021

Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900495-9

7 January 2021

Dose intensity analysis of chemotherapy regimens in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900495-9

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900495-9

7 January 2021

Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900495-9

7 January 2021

10.1016/S0959-8049(96)00495-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9274440%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference